Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives Average Rating of “Moderate Buy” from Analysts
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eight research firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has […]
30 Jul 08:49 · The Markets Daily